Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read Pharma Industry News Inside Azenta’s partnership with the PRECEDE Foundation driving breakthroughs in early pancreatic cancer diagnostics Discover how Azenta Life Sciences and the PRECEDE Foundation are building a global biobanking network to transform early pancreatic cancer detection. bySoujanya RaviNovember 5, 2025